ALPK1 and bacterial infectious disease: These mutations allow ALPK1 to be activated by endogenous mammalian nucleotide sugars, such as UDP-mannose and ADP-ribose, in addition to bacterial ADP-heptose, leading to pathological signaling in the absence of bacterial infection [3,6].